N-[4-[7-chloro-5-(5-morpholinopentylamino)-2,3,4,5-tetrahydro-1-benzazepine-1-carbonyl]-3-methyl-phenyl]-2-methyl-benzamide

ID: ALA5182998

Chembl Id: CHEMBL5182998

PubChem CID: 168282087

Max Phase: Preclinical

Molecular Formula: C35H43ClN4O3

Molecular Weight: 603.21

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCC(NCCCCCN3CCOCC3)c3cc(Cl)ccc32)c(C)c1

Standard InChI:  InChI=1S/C35H43ClN4O3/c1-25-9-4-5-10-29(25)34(41)38-28-13-14-30(26(2)23-28)35(42)40-18-8-11-32(31-24-27(36)12-15-33(31)40)37-16-6-3-7-17-39-19-21-43-22-20-39/h4-5,9-10,12-15,23-24,32,37H,3,6-8,11,16-22H2,1-2H3,(H,38,41)

Standard InChI Key:  HMYBLKVCHBORCM-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5182998

    ---

Associated Targets(Human)

AVPR2 Tclin Vasopressin V2 receptor (2912 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 603.21Molecular Weight (Monoisotopic): 602.3024AlogP: 6.78#Rotatable Bonds: 10
Polar Surface Area: 73.91Molecular Species: BASEHBA: 5HBD: 2
#RO5 Violations: 2HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 9.33CX LogP: 6.50CX LogD: 4.11
Aromatic Rings: 3Heavy Atoms: 43QED Weighted: 0.25Np Likeness Score: -1.56

References

1. Zhang H, Yan W, Sun Y, Yuan H, Su L, Cao X, Wang P, Xu Z, Hu Y, Wang Z, Wang Y, Fu K, Sun Y, Chen Y, Cheng J, Guo D..  (2022)  Long Residence Time at the Vasopressin V2 Receptor Translates into Superior Inhibitory Effects in Ex Vivo and In Vivo Models of Autosomal Dominant Polycystic Kidney Disease.,  65  (11.0): [PMID:35363466] [10.1021/acs.jmedchem.2c00011]

Source